Harbinger Health

News

Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.

News

Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.